Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Clinical trial NCT07053852 · COMPLETED
Trial details
- NCT number
- NCT07053852
- Sponsor
- Sherrif Ibrahim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2025-12-29
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.